Johnson Fistel Investigates Simulations Plus Following Reports of Financial and Internal Control Issues

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Simulations Plus, Inc. regarding possible violations of federal securities laws, particularly related to alleged misrepresentations and omissions by the company and its executives [1] Company Background - Simulations Plus is a software company that serves the pharmaceutical, biotechnology, and chemical industries [3] - In June 2024, the company acquired Pro-ficiency Holdings, Inc., claiming this acquisition would double its total addressable market and serve as a key driver of growth [3] Recent Developments - On June 11, 2025, Simulations Plus announced disappointing preliminary results for Q3 2025, attributing the downturn to "market uncertainties," which led to a stock price drop of over 24%, from $26.44 to $20.05 per share [4] - Following this, on July 14, 2025, the company reported a $77.2 million charge related to prior acquisitions and dismissed its auditor, Grant Thornton LLP, which raised concerns about unresolved issues with segment reporting and internal controls [4] - The dismissal of the auditor and the acknowledgment of unresolved issues caused the stock to fall nearly 26%, from $17.47 to $12.97 per share [4]